A phase II study of weekly docetaxel in combination with capecitabine in advanced gastric and gastroesophageal adenocarcinomas. [electronic resource]
Producer: 20100528Description: 125-9 p. digitalISSN:- 1423-0232
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Aged, 80 and over
- Antimetabolites, Antineoplastic -- therapeutic use
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Capecitabine
- Deoxycytidine -- administration & dosage
- Docetaxel
- Esophageal Neoplasms -- drug therapy
- Female
- Fluorouracil -- administration & dosage
- Humans
- Male
- Middle Aged
- Neoplasm Staging
- Outpatients
- Patient Selection
- Stomach Neoplasms -- drug therapy
- Survival Analysis
- Taxoids -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.